0
0
NEW DELHI – In a move that could fundamentally reshape the landscape of Indian healthcare, the Supreme Court of India on Tuesday agreed to examine a Public Interest Litigation (PIL) that seeks to exempt medical professionals from the jurisdiction of the Consumer Protection Act (CPA), 2019.
A Bench led by Chief Justice of India Surya Kant, along with Justices Joymalya Bagchi and N.V. Anjaria, issued notices to the Union Ministry of Health and Family Welfare, the Ministry of Consumer Affairs, and the National Medical Commission (NMC). The court’s decision to revisit this decades-old legal precedent follows growing concerns that the “consumerist” approach to medicine is eroding the sanctity of the doctor-patient relationship and driving up healthcare costs through defensive medicine.
The Core of the Contention
The PIL, filed by the Association of Healthcare Providers (India) and Dr. Alexander Thomas, argues that medical professionals holding MBBS or higher qualifications should be excluded from the definition of “service” under Section 2(42) of the CPA.
The petitioners contend that medicine is a “noble profession” rather than a commercial enterprise. They argue that the current legal framework treats a lifesaving surgery with the same consumer-provider lens as a faulty home appliance or a delayed flight—a comparison they claim is fundamentally flawed due to the biological uncertainties inherent in human health.
The Legal Precedent: Why Now?
The push for this change stems from a landmark 2024 Supreme Court ruling in Bar of Indian Lawyers vs. D.K. Gandhi. In that case, the court held that advocates—legal professionals—could not be sued for “deficiency of service” under the CPA because the legislature never intended to include professionals under a statute designed to curb unfair trade practices.
However, doctors are still governed by a 1995 precedent set in Indian Medical Association v. V.P. Shantha, which explicitly brought medical services under the consumer law.
“The patient-doctor relationship occupies a singular and sacrosanct space,” the petition states. “Since the inclusion of the medical profession under the Consumer Protection Act, this relationship has regrettably become transactional.”
The Rise of “Defensive Medicine”
One of the most significant arguments presented to the court is the rise of defensive medicine. When doctors fear that a negative outcome—even one caused by the natural progression of a disease—could lead to years of litigation in a consumer forum, they often change how they practice.
Common defensive practices include:
-
Over-testing: Ordering redundant diagnostic tests (MRIs, CT scans) to “paper the file” against potential lawsuits.
-
Referral Bias: Avoiding high-risk patients or complex cases that carry a higher chance of complications.
-
Increased Costs: These unnecessary tests and administrative burdens are ultimately passed on to the patient, making healthcare less affordable.
“When a physician’s primary focus shifts from ‘what is best for the patient’ to ‘what will protect me in court,’ the quality of care inevitably suffers,” says Dr. Rajesh Kumar, a healthcare policy analyst not involved in the litigation. “It creates a culture of suspicion rather than trust.”
The Patient’s Perspective: Speed vs. Justice
The original intent of including doctors under the CPA was to provide patients with a speedy, low-cost alternative to civil courts for addressing medical negligence. However, the PIL argues that the system has failed this objective.
Statistically, consumer forums in India face massive backlogs. Cases often drag on for 5 to 10 years, defeating the “summary procedure” intended by the Act. For medical professionals, these prolonged battles can be devastating. The petition highlights the experience of Dr. Alexander Thomas, who spent years defending a case related to a road accident victim in the 1990s. Though the case was eventually dismissed, the “demoralizing” impact nearly drove him to quit the profession.
Potential Implications and Counterarguments
While the medical fraternity largely supports the move, patient advocacy groups express caution.
“Excluding doctors from the CPA would leave patients with the only option of filing a civil suit or a criminal complaint,” notes Meera Sahni, a representative for a patient rights NGO. “Civil suits in India are notoriously slow and expensive. Without the CPA, an average citizen might have no realistic way to hold a negligent provider accountable.”
The Middle Ground
Legal experts suggest that if the Supreme Court excludes doctors from the CPA, it may necessitate a more robust, specialized tribunal system.
-
Medical Tribunals: A specialized body consisting of both legal experts and medical professionals to evaluate negligence.
-
NMC Oversight: Strengthening the National Medical Commission’s ability to revoke licenses for unethical behavior or gross negligence.
What This Means for You
For the average patient, the outcome of this case could change the “check-out” experience at the hospital. If doctors are excluded:
-
Trust-Based Care: In theory, doctors may feel more empowered to offer nuanced advice without fearing litigation for every minor complication.
-
Lower Diagnostic Costs: A reduction in defensive medicine could lead to fewer unnecessary tests.
-
Recourse Changes: If a patient experiences genuine negligence, the process for seeking compensation may become more complex, shifting from consumer forums to civil courts or medical boards.
Next Steps
The Union Ministries and the National Medical Commission are expected to file their responses in the coming weeks. The Supreme Court has indicated that the 1995 V.P. Shantha ruling “deserves to be revisited” by a larger Bench, signaling that a major shift in Indian medical law is on the horizon.
References
- https://tennews.in/sc-issues-notice-on-pil-to-exclude-doctors-from-consumer-protection-act/
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
